Elanco Animal Health Incorporated (ELAN) vs United Therapeutics Corporation (UTHR)
- Elanco Animal Health Incorporated ELAN 23.55 +0.04%
- United Therapeutics Corporation UTHR 533.12 −1.55%
Elanco Animal Health Incorporated and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. United Therapeutics Corporation is the larger, with a market value of $23.2B against $11.8B — 2.0× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; United Therapeutics Corporation trades at 17.6×. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 2.49%. United Therapeutics Corporation has the higher net margin (41.6% vs −3.96%) and the higher return on invested capital (23.4% vs 0.51%). Across the 21 metrics below, United Therapeutics Corporation leads on 17 and Elanco Animal Health Incorporated on 4.
Valuation
Profitability
| Metric | ELAN | UTHR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.36% | 86.14% | 53.94% |
| Operating margin | 1.61% | 44.44% | 0.00% |
| Net margin | (3.96%) | 41.56% | 0.00% |
| Free cash flow margin | 7.55% | 34.65% | 0.00% |
| Return on equity | (2.98%) | 19.32% | (0.40%) |
| Return on assets | (1.46%) | 17.33% | (3.32%) |
| Return on invested capital | 0.51% | 23.44% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack